What is he best known for?
The fields of study he is best known for:
- Bacteria
- Internal medicine
- Antibiotics
The scientist’s investigation covers issues in Microbiology, Meropenem, Klebsiella pneumoniae, Imipenem and Drug resistance.
His Microbiology study combines topics in areas such as Pseudomonas aeruginosa and Beta-lactamase.
His studies in Meropenem integrate themes in fields like Ceftazidime and Metallo β lactamase.
Spyros Pournaras has researched Klebsiella pneumoniae in several fields, including Plasmid, Antimicrobial, Colistin, Cefepime and Case-control study.
His Drug resistance research is multidisciplinary, incorporating perspectives in Outbreak, Antibacterial agent, Acinetobacter baumannii and Genotype.
His Genotype research is multidisciplinary, incorporating elements of Internal medicine, Antibiotic resistance and Mobile genetic elements.
His most cited work include:
- Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages (322 citations)
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. (296 citations)
- Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues (271 citations)
What are the main themes of his work throughout his whole career to date?
Microbiology, Imipenem, Meropenem, Acinetobacter baumannii and Klebsiella pneumoniae are his primary areas of study.
His Microbiology research includes elements of Pseudomonas aeruginosa, Gene and Virology.
His Meropenem research integrates issues from Agar dilution and Carbapenem.
His Acinetobacter baumannii research is multidisciplinary, relying on both Molecular epidemiology, Neisseriaceae, Allele and Pulsed-field gel electrophoresis.
His Klebsiella pneumoniae study incorporates themes from Cefotaxime, Cefepime, Enterobacteriaceae and Beta-lactamase.
The study incorporates disciplines such as Antibiotic resistance and Genotype in addition to Drug resistance.
He most often published in these fields:
- Microbiology (70.99%)
- Imipenem (20.61%)
- Meropenem (19.85%)
What were the highlights of his more recent work (between 2010-2021)?
- Microbiology (70.99%)
- Internal medicine (14.50%)
- Outbreak (10.69%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Microbiology, Internal medicine, Outbreak, Meropenem and Pulsed-field gel electrophoresis.
His Microbiology research includes themes of Multilocus sequence typing, Acinetobacter baumannii and Virulence.
His research in Internal medicine intersects with topics in Endocrinology and Surgery.
His Meropenem study combines topics from a wide range of disciplines, such as Klebsiella pneumoniae and Imipenem.
His Imipenem research incorporates elements of Efflux, Pathogen and Carbapenem.
His Pulsed-field gel electrophoresis course of study focuses on Agar dilution and Outpatient clinic and Klebsiella oxytoca.
Between 2010 and 2021, his most popular works were:
- Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages (322 citations)
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. (296 citations)
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay (110 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Internal medicine
- Antibiotics
His primary areas of investigation include Microbiology, Internal medicine, Klebsiella pneumoniae, Meropenem and Acinetobacter baumannii.
His research ties Gram and Microbiology together.
His Internal medicine study integrates concerns from other disciplines, such as Surgery and Intensive care.
His work carried out in the field of Meropenem brings together such families of science as Carbapenem and Imipenem.
His Imipenem research incorporates themes from Enterobacteriaceae and Typing.
He usually deals with Acinetobacter baumannii and limits it to topics linked to Molecular epidemiology and Lineage, Mobile genetic elements, Antibiotic resistance and Drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
